You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 157 No. 17, 22 SEPTEMBER 1997 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (73)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Adult Bacteremic Pneumococcal Pneumonia in a Community Teaching Hospital, 1992-1996n

A Detailed Analysis of 108 Cases

Chatrchai Watanakunakorn, MD; Thomas A. Bailey

Arch Intern Med. 1997;157(17):1965-1971.


Abstract



Objectives
To review the clinical and laboratory findings of 108 adult patients with bacteremic pneumococcal pneumonia admitted to a community hospital and to determine the value of sputum Gram stains and cultures in the diagnosis of pneumococcal pneumonia in this setting.

Methods
Using the laboratory logbooks to identify adult inpatients with pneumococcal bacteremia from January 1, 1992, to June 30, 1996, we reviewed medical records.

Results
We found 108 patients. There was an apparent increase in prevalence from 1995 to 1996 compared with 1992 to 1994. Patients included 44 men and 64 women. Ages ranged from 20 to 95 years (median, 70 years). The fatality rate was 24.1% and increased with advancing age (no patient younger than 45 years died, and 36.8% of patients aged 85-95 years died). Cigarette smoking, cardiovascular disease, chronic obstructive lung disease, malignant disease, and diabetes mellitus were major underlying conditions. Fever, dyspnea, and cough were the most common presenting symptoms. Sputum Gram stain was useful in the diagnosis when moderate to abundant Gram-positive diplococci were seen. Sputum culture was less useful. Factors associated with higher fatality rate were being 65 years of age or older, APACHE II (Acute Physiologic and Chronic Health Evaluation II) score greater than 15, intensive care unit admission, low or normal leukocyte count, thrombocytopenia, renal dysfunction, diffused infiltrates on chest radiography, bilateral pneumonia, and sputum culture positive for Streptococcus pneumoniae.

Conclusions
We found a recent increase in the prevalence of bacteremic pneumococcal pneumonia in adults. Gram stain of sputum is useful, but sputum culture is less sensitive in the diagnosis of pneumococcal pneumonia. The fatality rate remains high. More effort should be made at prevention using pneumococcal immunization.

Arch Intern Med. 1997;157:1965-1971



Author Affiliations



From the Infectious Disease Section, Department of Internal Medicine, St Elizabeth Health Center, Youngstown, Ohio (Dr Watanakunakorn), and the Northeastern Ohio Universities College of Medicine, Rootstown (Dr Watanakunakorn and Mr Bailey).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
Mandell et al.
Clinical Infectious Diseases 2007;44:S27-S72.
FULL TEXT  

Sporadic and epidemic community legionellosis: two faces of the same illness
Sopena et al.
Eur Respir J 2007;29:138-142.
ABSTRACT | FULL TEXT  

Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia
Spindler and Ortqvist
Eur Respir J 2006;28:816-823.
ABSTRACT | FULL TEXT  

Clonal and Capsular Types Decide Whether Pneumococci Will Act as a Primary or Opportunistic Pathogen
Sjostrom et al.
Clinical Infectious Diseases 2006;42:451-459.
ABSTRACT | FULL TEXT  

The Controversy of Combination vs Monotherapy in the Treatment of Hospitalized Community-Acquired Pneumonia
Weiss and Tillotson
Chest 2005;128:940-946.
ABSTRACT | FULL TEXT  

In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants
Croisier et al.
J Antimicrob Chemother 2004;54:640-647.
ABSTRACT | FULL TEXT  

Diagnostic Value of Microscopic Examination of Gram-Stained Sputum and Sputum Cultures in Patients with Bacteremic Pneumococcal Pneumonia
Musher et al.
Clinical Infectious Diseases 2004;39:165-169.
ABSTRACT | FULL TEXT  

Mutant Selection Window in Levofloxacin and Moxifloxacin Treatments of Experimental Pneumococcal Pneumonia in a Rabbit Model of Human Therapy
Croisier et al.
Antimicrob. Agents Chemother. 2004;48:1699-1707.
ABSTRACT | FULL TEXT  

Cumulative Clinical Trial Experience with Levofloxacin for Patients with Community-Acquired Pneumonia-Associated Pneumococcal Bacteremia
Kahn et al.
Clinical Infectious Diseases 2004;38:S34-S42.
ABSTRACT | FULL TEXT  

Pneumococcal Septic Arthritis: Review of 190 Cases
Ross et al.
Clinical Infectious Diseases 2003;36:319-327.
ABSTRACT | FULL TEXT  

Hospital-Acquired Pneumococcal Bacteremia
Canet et al.
Clinical Infectious Diseases 2002;35:697-702.
ABSTRACT | FULL TEXT  

Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones
Croisier et al.
J Antimicrob Chemother 2002;50:349-360.
ABSTRACT | FULL TEXT  

An Intervention To Improve Antibiotic Delivery and Sputum Procurement in Patients Hospitalized With Community-Acquired Pneumonia*
Lawrence et al.
Chest 2002;122:913-919.
ABSTRACT | FULL TEXT  

Resolution of Pleural Effusions
Cohen and Sahn
Chest 2001;119:1547-1562.
FULL TEXT  

Antipneumolysin Antibody Titers in HIV-Seropositive Injection Drug Users before and after Pneumococcal Bacteremia
SULLIVAN et al.
Am. J. Respir. Crit. Care Med. 2001;163:680-684.
ABSTRACT | FULL TEXT  

Leucocyte response and anti-inflammatory cytokines in community acquired pneumonia
Kolling et al.
Thorax 2001;56:121-125.
ABSTRACT | FULL TEXT  

HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae
Piroth et al.
J Antimicrob Chemother 2001;47:33-42.
ABSTRACT | FULL TEXT  

Kinetic Study of the Inflammatory Response in Streptococcus pneumoniae Experimental Pneumonia Treated with the Ketolide HMR 3004
Duong et al.
Antimicrob. Agents Chemother. 2001;45:252-262.
ABSTRACT | FULL TEXT  

Prospective Study of the Usefulness of Sputum Gram Stain in the Initial Approach to Community-Acquired Pneumonia Requiring Hospitalization
Roson et al.
Clinical Infectious Diseases 2000;31:869-874.
ABSTRACT | FULL TEXT  

Prospective Study of Prognostic Factors in Community-Acquired Bacteremic Pneumococcal Disease in 5 Countries
Kalin et al.
The Journal of Infectious Disease 2000;182:840-847.
ABSTRACT | FULL TEXT  

Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society
Mandell et al.
Clinical Infectious Diseases 2000;31:383-421.
FULL TEXT  

Antibody to Capsular Polysaccharide of Streptococcus pneumoniae at the Time of Hospital Admission for Pneumococcal Pneumonia
Musher et al.
The Journal of Infectious Disease 2000;182:158-167.
ABSTRACT | FULL TEXT  

Diagnosis of pneumococcal pneumonia by polymerase chain reaction (PCR) in whole blood: a prospective clinical study
Lorente et al.
Thorax 2000;55:133-137.
ABSTRACT | FULL TEXT  

Development of a New Experimental Model of Penicillin-Resistant Streptococcus pneumoniae Pneumonia and Amoxicillin Treatment by Reproducing Human Pharmacokinetics
Piroth et al.
Antimicrob. Agents Chemother. 1999;43:2484-2492.
ABSTRACT | FULL TEXT  

The Significance of Serum vs Tissue Levels of Antibiotics in the Treatment of Penicillin-Resistant Streptococcus pneumoniae and Community-Acquired Pneumonia: Are We Looking in the Wrong Place?
Siegel
Chest 1999;116:535-538.
FULL TEXT  

Bacteremic Pneumococcal Pneumonia in HIV-Seropositive and HIV-Seronegative Adults
Feldman et al.
Chest 1999;116:107-114.
ABSTRACT | FULL TEXT  

Value of the Polymerase Chain Reaction Assay in Noninvasive Respiratory Samples for Diagnosis of Community-acquired Pneumonia
MENENDEZ et al.
Am. J. Respir. Crit. Care Med. 1999;159:1868-1873.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.